Research on blood stem cells to develop an alternative to chemotherapy

Blood stem cells have always been the main thread of the IRHT researches.

Cellules Souches Sanguines, Traitement LeucémieOur studies are divided into 3 complementary subjects whose objectives are:

  • Identifying, understanding and multiplying adult pluripotent stem cells (VSEL)
  • Studying cardiac differentiation of blood stem cells
  • Understanding the mechanisms of blood stem cell diseases that can develop into leukemia (Myelodysplastic syndromes)

Myelodysplastic syndrome project

What are myelodysplastic syndromes? Myelodysplastic syndromes (MDS) characterize a group of bone marrow abnormalities resulting in ineffective hematopoiesis. To sum up, the differentiation process of hematopoietic stem cells (HSCs) in all three blood cell types (red blood cells,…
Learn more

Cardiomyoplasty project

Severe heart failure is a major public health problem worldwide. This disease develops as a result of myocardial infarction and is characterized by the irreversible destruction of many cardiac cells. Different approaches of cell therapy are being tested today to restore heart tissue…
Learn more

VSELs project

As for stem cell transplants, currently a routine treatment for leukemia, regenerative medicine remains a hope for the treatment of other diseases such as myocardial infarction and diabetes. It consists of repairing a lesion or a diseased organ by replacing the damaged parts with multipotent…
Learn more

Testimonials

Since its creation, IRHT’s discoveries and applications in research therapy have saved many lives. Patients are talking about it better than we can……
Learn more